Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Option Activity Rollforward) (Details)

v3.3.1.900
Stockholders' Equity (Option Activity Rollforward) (Details) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Jun. 30, 2015
Equity [Abstract]          
Share-based compensation expense $ 38,670 $ 37,644 $ 77,341 $ 77,220  
Total compensation cost not yet recognized $ 300,000   $ 300,000    
Period for recognition of nonvested awards (in years)     1 year 9 months 29 days    
Options          
Options, beginning balance (shares)     233,127    
Granted through stock option plan (shares)     0    
Exercised (shares)     0    
Cancellations, expirations and forfeitures (shares)     0    
Options, ending balance (shares) 233,127   233,127    
Shares exercisable at end of the period 182,184   182,184    
Weighted Average Exercise Price Per Share          
Beginning balance (in dollars per share)     $ 9.89    
Granted through stock option plan (in dollars per share)     0.00    
Exercised (in dollars per share)     0.00    
Cancellations, expirations and forfeitures (in dollars per share)     0.00    
Ending balance (in dollars per share) $ 9.89   9.89    
Shares exercisable at end of period (in dollars per share) $ 10.30   $ 10.30    
Intrinsic value, balance $ 2,088,000   $ 2,088,000   $ 283,000
Intrinsic Value, Shares exercisable at end of period $ 1,558,000   $ 1,558,000    
Weighted Average per share Grant Date Fair Value, beginning balance (in dollars per share) $ 5.96   $ 5.96   $ 5.96
Weighted Average per share Grant Date Fair Value, Shares exercisable at end of period (in dollars per share) $ 5.92   $ 5.92